# Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

> **NCT00170885** · PHASE4 · COMPLETED · sponsor: **Novartis**

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT00170885
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** — (—)
- **Last updated:** 2016-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00170885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00170885, "Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00170885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*